Century Therapeutics, Inc. (IPSC)
2.025
-0.20
(-9.19%)
USD |
NASDAQ |
Aug 28, 16:00
2.025
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Free Cash Flow : -88.07M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -88.07M |
| March 31, 2026 | -95.45M |
| December 31, 2025 | -104.72M |
| September 30, 2025 | -113.16M |
| June 30, 2025 | -114.91M |
| March 31, 2025 | -114.60M |
| December 31, 2024 | -110.29M |
| September 30, 2024 | -113.12M |
| June 30, 2024 | -102.51M |
| March 31, 2024 | -98.66M |
| December 31, 2023 | -102.30M |
| September 30, 2023 | -104.40M |
| Date | Value |
|---|---|
| June 30, 2023 | -121.66M |
| March 31, 2023 | -134.04M |
| December 31, 2022 | -17.05M |
| September 30, 2022 | -28.95M |
| June 30, 2022 | -34.62M |
| March 31, 2022 | -28.13M |
| December 31, 2021 | -134.76M |
| September 30, 2021 | -110.19M |
| June 30, 2021 | -84.07M |
| March 31, 2021 | -65.57M |
| December 31, 2020 | -51.09M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Tenax Therapeutics, Inc. | -46.03M |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | -6.385M |
| Absci Corp. | -108.97M |
| Celularity, Inc. | -13.25M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.83M |
| Cash from Investing (Quarterly) | 17.77M |
| Cash from Financing (Quarterly) | 0.311M |
| Free Cash Flow Per Share (Quarterly) | -0.0998 |
| Free Cash Flow to Equity (Quarterly) | -11.17M |
| Free Cash Flow to Firm (Quarterly) | -20.53M |
| Free Cash Flow Yield | -30.35% |